Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 29.13M 33.4M 27.5M 24.97M 46.79M 3.21B 46.99M 329M 127M 1.63B 125M 123M 5.24B | P/E 2026 * |
-6.61x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 29.13M 33.4M 27.5M 24.97M 46.79M 3.21B 46.99M 329M 127M 1.63B 125M 123M 5.24B | EV / Sales 2026 * |
9.71x | EV / Sales 2027 * | 2.91x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 2024-02-27 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 2014-12-31 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 2024-04-07 |
Damian Marron
CHM | Chairman | 64 | 2024-07-15 |
Marc Bozec
BRD | Director/Board Member | - | 2024-07-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 33.44M | |
| -0.18% | +1.88% | +79.85% | +36.00% | 363B | |
| -1.22% | -1.22% | +20.85% | -19.25% | 65.62B | |
| +2.22% | +4.54% | +46.15% | +186.55% | 12.45B | |
| -0.29% | +2.27% | -5.37% | -16.54% | 7.6B | |
| -1.89% | -6.83% | -27.65% | -14.90% | 4.49B | |
| -2.06% | -3.80% | -34.68% | +5.56% | 4.19B | |
| +1.48% | +2.36% | -31.20% | -13.91% | 2.92B | |
| -2.07% | +1.46% | -8.41% | +49.24% | 2.49B | |
| -0.41% | -0.71% | -28.25% | -33.78% | 1.93B | |
| Average | -1.27% | +0.50% | +1.25% | +19.89% | 51.64B | |
| Weighted average by Cap. | -0.34% | +1.38% | +65.53% | +30.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.44M 2.83M 2.57M 4.82M 330M 4.84M 33.93M 13.09M 168M 12.92M 12.64M 540M | 10M 11.47M 9.44M 8.57M 16.06M 1.1B 16.13M 113M 43.65M 559M 43.08M 42.12M 1.8B |
| Net income | -5M -5.73M -4.72M -4.29M -8.03M -550M -8.07M -56.55M -21.82M -280M -21.54M -21.06M -900M | 2M 2.29M 1.89M 1.71M 3.21M 220M 3.23M 22.62M 8.73M 112M 8.62M 8.42M 360M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
